25 XP   0   0   10

CASI Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse CASI Pharmaceuticals Inc together

PenkeI guess you are interested in CASI Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of CASI Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about CASI Pharmaceuticals Inc

I send you an email if I find something interesting about CASI Pharmaceuticals Inc.

Quick analysis of CASI Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of CASI Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.80
Expected worth in 1 year
$-1.30
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
$-3.10
Return On Investment
-132.5%

For what price can you sell your share?

Current Price per Share
$2.34
Expected price per share
$1.9 - $2.93
How sure are you?
50%

1. Valuation of CASI Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$2.34

2. Growth of CASI Pharmaceuticals Inc (5 min.)




Is CASI Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$24.1m$84.6m-$36.9m-77.5%

How much money is CASI Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$6.5m-$9.9m$3.3m50.9%
Net Profit Margin-79.6%-88.9%--

How much money comes from the company's main activities?

3. Financial Health of CASI Pharmaceuticals Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#567 / 1019

Most Revenue
#317 / 1019

Most Profit
#472 / 1019

Most Efficient
#558 / 1019

What can you expect buying and holding a share of CASI Pharmaceuticals Inc? (5 min.)

Welcome investor! CASI Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of CASI Pharmaceuticals Inc.

What can you expect buying and holding a share of CASI Pharmaceuticals Inc?

First you should know what it really means to hold a share of CASI Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of CASI Pharmaceuticals Inc is $2.34. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of CASI Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in CASI Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.80. Based on the TTM, the Book Value Change Per Share is $-0.78 per quarter. Based on the YOY, the Book Value Change Per Share is $1.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of CASI Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.41-17.4%-0.57-24.4%-0.58-24.8%-0.61-26.0%-0.43-18.2%
Usd Book Value Change Per Share-1.96-83.8%-0.78-33.1%1.0344.1%0.031.4%0.031.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.96-83.8%-0.78-33.1%1.0344.1%0.031.4%0.031.3%
Usd Price Per Share7.16-3.64-2.01-2.50-2.38-
Price to Earnings Ratio-4.39--1.96--0.97--1.78--2.90-
Price-to-Total Gains Ratio-3.65--6.65--2.98--2.75--3.42-
Price to Book Ratio3.97-1.44-0.33-0.87--1.38-
Price-to-Total Gains Ratio-3.65--6.65--2.98--2.75--3.42-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.34
Number of shares427
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.780.03
Usd Total Gains Per Share-0.780.03
Gains per Quarter (427 shares)-331.0514.06
Gains per Year (427 shares)-1,324.2156.26
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1324-133405646
20-2648-26580113102
30-3973-39820169158
40-5297-53060225214
50-6621-66300281270
60-7945-79540338326
70-9269-92780394382
80-10594-106020450438
90-11918-119260506494
100-13242-132500563550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%4.0111.00.03.5%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%14.026.00.035.0%38.074.03.033.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%3.00.0112.02.6%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%14.026.00.035.0%38.074.03.033.0%

Fundamentals of CASI Pharmaceuticals Inc

About CASI Pharmaceuticals Inc

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People's Republic of China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's other hematology/oncology assets in pipeline include CNCT 19, an autologous CD19 CAR-T investigative product; BI-1206, novel anti-Fc"RIIB antibody, for the treatment of solid tumors and relapsed/refractory non-hodgkin lymphoma; CB-5339, a novel VCP/p97 inhibitor that focuses on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis, DNA damage response, and other cellular stress pathways for therapeutic use in the treatment of patients with various malignancies; and CID-103, a human IgG1 anti-CD38 monoclonal antibody. The company has licensing agreements with Juventas Biotechnology (Tianjin) Co., Ltd.; BioInvent International AB; Black Belt Therapeutics Limited; Cleave Therapeutics, Inc.; and Acrotech Biopharma L.L.C. to develop and commercialize its commercial product EVOMELA. It also has distribution agreements with China Resources Pharmaceutical Commercial Group International Trading Co., Ltd; Pharmathen Global BV; and Riemser Pharma GmbH. CASI Pharmaceuticals, Inc. was incorporated in 1991 and is based in Beijing, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-11 03:35:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of CASI Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit CASI Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare CASI Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -89.7% means that $-0.90 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CASI Pharmaceuticals Inc:

  • The MRQ is -89.7%. The company is making a huge loss. -2
  • The TTM is -79.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-89.7%TTM-79.6%-10.1%
TTM-79.6%YOY-88.9%+9.4%
TTM-79.6%5Y-188.7%+109.1%
5Y-188.7%10Y-1,723.3%+1,534.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-89.7%-197.2%+107.5%
TTM-79.6%-210.4%+130.8%
YOY-88.9%-279.3%+190.4%
5Y-188.7%-436.8%+248.1%
10Y-1,723.3%-599.3%-1,124.0%
1.1.2. Return on Assets

Shows how efficient CASI Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare CASI Pharmaceuticals Inc to the Biotechnology industry mean.
  • -7.3% Return on Assets means that CASI Pharmaceuticals Inc generated $-0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CASI Pharmaceuticals Inc:

  • The MRQ is -7.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.3%TTM-8.4%+1.1%
TTM-8.4%YOY-9.0%+0.7%
TTM-8.4%5Y-8.9%+0.5%
5Y-8.9%10Y-14.7%+5.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.3%-13.6%+6.3%
TTM-8.4%-12.9%+4.5%
YOY-9.0%-11.9%+2.9%
5Y-8.9%-14.2%+5.3%
10Y-14.7%-16.2%+1.5%
1.1.3. Return on Equity

Shows how efficient CASI Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare CASI Pharmaceuticals Inc to the Biotechnology industry mean.
  • -22.6% Return on Equity means CASI Pharmaceuticals Inc generated $-0.23 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CASI Pharmaceuticals Inc:

  • The MRQ is -22.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -21.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-22.6%TTM-21.4%-1.2%
TTM-21.4%YOY-18.0%-3.4%
TTM-21.4%5Y-15.7%-5.7%
5Y-15.7%10Y-77.0%+61.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.6%-17.0%-5.6%
TTM-21.4%-16.1%-5.3%
YOY-18.0%-15.4%-2.6%
5Y-15.7%-20.0%+4.3%
10Y-77.0%-21.1%-55.9%

1.2. Operating Efficiency of CASI Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient CASI Pharmaceuticals Inc is operating .

  • Measures how much profit CASI Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare CASI Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of -30.9% means the company generated $-0.31  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CASI Pharmaceuticals Inc:

  • The MRQ is -30.9%. The company is operating very inefficient. -2
  • The TTM is -67.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-30.9%TTM-67.5%+36.6%
TTM-67.5%YOY-39.2%-28.4%
TTM-67.5%5Y-126.6%+59.1%
5Y-126.6%10Y-1,667.1%+1,540.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-30.9%-286.1%+255.2%
TTM-67.5%-224.4%+156.9%
YOY-39.2%-288.4%+249.2%
5Y-126.6%-475.2%+348.6%
10Y-1,667.1%-624.7%-1,042.4%
1.2.2. Operating Ratio

Measures how efficient CASI Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.67 means that the operating costs are $2.67 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of CASI Pharmaceuticals Inc:

  • The MRQ is 2.674. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.022. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.674TTM2.022+0.652
TTM2.022YOY1.666+0.355
TTM2.0225Y2.534-0.512
5Y2.53410Y19.087-16.553
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6742.997-0.323
TTM2.0223.247-1.225
YOY1.6663.766-2.100
5Y2.5345.675-3.141
10Y19.0877.857+11.230

1.3. Liquidity of CASI Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if CASI Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.55 means the company has $3.55 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of CASI Pharmaceuticals Inc:

  • The MRQ is 3.548. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.582. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.548TTM4.582-1.034
TTM4.582YOY3.299+1.284
TTM4.5825Y7.956-3.374
5Y7.95610Y10.250-2.294
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5483.930-0.382
TTM4.5824.251+0.331
YOY3.2995.436-2.137
5Y7.9566.045+1.911
10Y10.2506.363+3.887
1.3.2. Quick Ratio

Measures if CASI Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare CASI Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 3.26 means the company can pay off $3.26 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CASI Pharmaceuticals Inc:

  • The MRQ is 3.264. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.162. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.264TTM5.162-1.898
TTM5.162YOY3.219+1.943
TTM5.1625Y8.011-2.849
5Y8.01110Y10.164-2.153
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2643.629-0.365
TTM5.1624.065+1.097
YOY3.2195.397-2.178
5Y8.0115.993+2.018
10Y10.1646.277+3.887

1.4. Solvency of CASI Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of CASI Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare CASI Pharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.68 means that CASI Pharmaceuticals Inc assets are financed with 67.9% credit (debt) and the remaining percentage (100% - 67.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of CASI Pharmaceuticals Inc:

  • The MRQ is 0.679. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.401. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.679TTM0.401+0.278
TTM0.401YOY0.285+0.117
TTM0.4015Y0.216+0.185
5Y0.21610Y0.391-0.176
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6790.332+0.347
TTM0.4010.334+0.067
YOY0.2850.268+0.017
5Y0.2160.366-0.150
10Y0.3910.390+0.001
1.4.2. Debt to Equity Ratio

Measures if CASI Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare CASI Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 211.5% means that company has $2.11 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CASI Pharmaceuticals Inc:

  • The MRQ is 2.115. The company is just not able to pay all its debts with equity.
  • The TTM is 1.087. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ2.115TTM1.087+1.028
TTM1.087YOY0.557+0.530
TTM1.0875Y0.446+0.641
5Y0.44610Y0.709-0.263
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1150.381+1.734
TTM1.0870.390+0.697
YOY0.5570.334+0.223
5Y0.4460.434+0.012
10Y0.7090.466+0.243

2. Market Valuation of CASI Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings CASI Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare CASI Pharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of -4.39 means the investor is paying $-4.39 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CASI Pharmaceuticals Inc:

  • The EOD is -1.436. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.393. Based on the earnings, the company is expensive. -2
  • The TTM is -1.955. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.436MRQ-4.393+2.957
MRQ-4.393TTM-1.955-2.438
TTM-1.955YOY-0.972-0.983
TTM-1.9555Y-1.781-0.174
5Y-1.78110Y-2.902+1.121
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.436-2.315+0.879
MRQ-4.393-2.560-1.833
TTM-1.955-2.664+0.709
YOY-0.972-4.122+3.150
5Y-1.781-6.258+4.477
10Y-2.902-6.108+3.206
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CASI Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.455+0.455
TTM-0.455YOY-1.054+0.599
TTM-0.4555Y-1.474+1.019
5Y-1.47410Y-3.672+2.199
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.251+3.251
TTM-0.455-3.545+3.090
YOY-1.054-5.595+4.541
5Y-1.474-8.315+6.841
10Y-3.672-8.708+5.036
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of CASI Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.97 means the investor is paying $3.97 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of CASI Pharmaceuticals Inc:

  • The EOD is 1.298. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.971. Based on the equity, the company is fair priced.
  • The TTM is 1.443. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.298MRQ3.971-2.673
MRQ3.971TTM1.443+2.528
TTM1.443YOY0.334+1.109
TTM1.4435Y0.869+0.574
5Y0.86910Y-1.381+2.250
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.2981.905-0.607
MRQ3.9712.111+1.860
TTM1.4432.095-0.652
YOY0.3342.836-2.502
5Y0.8693.443-2.574
10Y-1.3813.794-5.175
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of CASI Pharmaceuticals Inc.

3.1. Institutions holding CASI Pharmaceuticals Inc

Institutions are holding 2.07% of the shares of CASI Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Wellington Shields Capital Mgmt LLC0.99950.1189133146-20309-13.2345
2023-12-31Wellington Shields & Co., LLC0.33250.075344291-29875-40.2813
2023-12-31Renaissance Technologies Corp0.21840.0003291001130063.4831
2023-12-31Geode Capital Management, LLC0.166802222100
2023-12-31Franklin Resources Inc0.14820.000119743-34-0.1719
2023-12-31JANE STREET GROUP, LLC0.0941012538-9586-43.3285
2023-12-31Morgan Stanley - Brokerage Accounts0.010901453-100-6.4392
2023-12-31UBS Group AG0.00920122212220
2023-12-31BlackRock Inc0.00220296-28-8.642
2023-12-31West Paces Advisors Inc0.00080.000210000
2023-12-31SIMPLEX TRADING, LLC0.0004053530
2023-12-31JPMorgan Chase & Co0.000202500
2023-09-30Royal Bank of Canada0.000101800
2023-12-31Northwestern Mutual Wealth Management Co0.000101300
2023-12-31Colonial Trust Co / SC0.000101100
2023-12-31Kozak & Associates, Inc.0.000101000
2023-12-31Wells Fargo & Co00600
2023-12-31Bank of America Corp00300
2023-12-31Tower Research Capital LLC000-327-100
2023-09-30Northern Trust Corp000-10318-100
Total 1.98360.1948264249-58002-21.9%

3.2. Funds holding CASI Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Fidelity Nasdaq Composite Index0.16580.00082222100
2023-12-31Franklin U.S. Small Cap Equity I0.13860.14211857700
2023-12-31NT Quality SCC US Fund - L0.01580.00622111-155-6.8402
2023-12-31NT Quality Small Cap Core0.01580.00632111-155-6.8402
2023-12-31Dimensional US Small Cap CIT Class S0.01540.002720681034100
2023-12-31JNL/DFA US Small Cap A0.01250.002166900
2024-02-29Dimensional US Sm Company EUR Acc0.00230.000630600
2023-12-31AZL® DFA US Small Cap0.00110.000514200
Total 0.36730.161249205+724+1.5%

3.3. Insider Transactions

Insiders are holding 47.129% of the shares of CASI Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-09-08James HuangBUY333004.28
2022-09-06James HuangBUY191623.89
2022-08-26James HuangBUY395273.75
2022-08-24James HuangBUY50003.75
2022-08-22James HuangBUY231053.46
2022-08-19James HuangBUY1711163.27
2021-11-17Wei-wu HeBUY2000000.99

4. Summary

4.1. Key Performance Indicators

The key performance indicators of CASI Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.960-0.775-60%1.033-290%0.033-6051%0.031-6370%
Book Value Per Share--1.8033.557-49%6.190-71%5.671-68%3.562-49%
Current Ratio--3.5484.582-23%3.299+8%7.956-55%10.250-65%
Debt To Asset Ratio--0.6790.401+69%0.285+139%0.216+215%0.391+74%
Debt To Equity Ratio--2.1151.087+95%0.557+279%0.446+374%0.709+198%
Dividend Per Share----0%-0%-0%-0%
Eps---0.407-0.570+40%-0.580+42%-0.609+49%-0.425+4%
Gross Profit Margin--1.9431.654+17%1.481+31%1.370+42%1.185+64%
Market Cap31359276.000-206%95954024.00048714089.000+97%27472176.071+249%67381792.726+42%64387554.792+49%
Net Profit Margin---0.897-0.796-11%-0.889-1%-1.887+110%-17.233+1822%
Operating Margin---0.309-0.675+118%-0.392+27%-1.266+309%-16.671+5290%
Operating Ratio--2.6742.022+32%1.666+60%2.534+6%19.087-86%
Pb Ratio1.298-206%3.9711.443+175%0.334+1087%0.869+357%-1.381+135%
Pe Ratio-1.436+67%-4.393-1.955-55%-0.972-78%-1.781-59%-2.902-34%
Price Per Share2.340-206%7.1603.635+97%2.015+255%2.503+186%2.379+201%
Price To Free Cash Flow Ratio----0.4550%-1.0540%-1.4740%-3.6720%
Price To Total Gains Ratio-1.194+67%-3.653-6.649+82%-2.976-19%-2.755-25%-3.416-6%
Quick Ratio--3.2645.162-37%3.219+1%8.011-59%10.164-68%
Return On Assets---0.073-0.084+15%-0.090+25%-0.089+23%-0.147+103%
Return On Equity---0.226-0.214-5%-0.180-20%-0.157-31%-0.770+241%
Total Gains Per Share---1.960-0.775-60%1.033-290%0.033-6051%0.031-6370%
Usd Book Value--24165000.00047666500.000-49%84616250.000-71%90315181.500-73%58325073.550-59%
Usd Book Value Change Per Share---1.960-0.775-60%1.033-290%0.033-6051%0.031-6370%
Usd Book Value Per Share--1.8033.557-49%6.190-71%5.671-68%3.562-49%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.407-0.570+40%-0.580+42%-0.609+49%-0.425+4%
Usd Free Cash Flow----1067250.0000%-6675000.0000%-7789350.0000%-5743221.4000%
Usd Market Cap31359276.000-206%95954024.00048714089.000+97%27472176.071+249%67381792.726+42%64387554.792+49%
Usd Price Per Share2.340-206%7.1603.635+97%2.015+255%2.503+186%2.379+201%
Usd Profit---5461000.000-6586000.000+21%-9937750.000+82%-9853389.600+80%-6954294.475+27%
Usd Revenue--6091000.0008274000.000-26%10776750.000-43%6282150.000-3%3145839.350+94%
Usd Total Gains Per Share---1.960-0.775-60%1.033-290%0.033-6051%0.031-6370%
 EOD+3 -4MRQTTM+11 -17YOY+12 -165Y+11 -1710Y+14 -14

4.2. Fundamental Score

Let's check the fundamental score of CASI Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.436
Price to Book Ratio (EOD)Between0-11.298
Net Profit Margin (MRQ)Greater than0-0.897
Operating Margin (MRQ)Greater than0-0.309
Quick Ratio (MRQ)Greater than13.264
Current Ratio (MRQ)Greater than13.548
Debt to Asset Ratio (MRQ)Less than10.679
Debt to Equity Ratio (MRQ)Less than12.115
Return on Equity (MRQ)Greater than0.15-0.226
Return on Assets (MRQ)Greater than0.05-0.073
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of CASI Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.915
Ma 20Greater thanMa 503.057
Ma 50Greater thanMa 1004.439
Ma 100Greater thanMa 2005.372
OpenGreater thanClose2.300
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Debt  -45,76829,175-16,593-322-16,915-3,061-19,97621,7881,812
Income Tax Expense  1,980-1,92852-511175176-257-81



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets75,268
Total Liabilities51,103
Total Stockholder Equity24,165
 As reported
Total Liabilities 51,103
Total Stockholder Equity+ 24,165
Total Assets = 75,268

Assets

Total Assets75,268
Total Current Assets59,344
Long-term Assets15,924
Total Current Assets
Cash And Cash Equivalents 17,083
Short-term Investments 13,686
Net Receivables 10,138
Inventory 15,877
Other Current Assets 2,560
Total Current Assets  (as reported)59,344
Total Current Assets  (calculated)59,344
+/-0
Long-term Assets
Property Plant Equipment 11,633
Long Term Investments 1,681
Intangible Assets 1,839
Long-term Assets Other 766
Long-term Assets  (as reported)15,924
Long-term Assets  (calculated)15,919
+/- 5

Liabilities & Shareholders' Equity

Total Current Liabilities16,726
Long-term Liabilities34,377
Total Stockholder Equity24,165
Total Current Liabilities
Short-term Debt 728
Accounts payable 4,438
Other Current Liabilities 9,017
Total Current Liabilities  (as reported)16,726
Total Current Liabilities  (calculated)14,183
+/- 2,543
Long-term Liabilities
Long term Debt 18,895
Capital Lease Obligations 2,344
Long-term Liabilities Other 11,821
Long-term Liabilities  (as reported)34,377
Long-term Liabilities  (calculated)33,060
+/- 1,317
Total Stockholder Equity
Common Stock1
Retained Earnings -660,817
Accumulated Other Comprehensive Income -1,200
Other Stockholders Equity 686,181
Total Stockholder Equity (as reported)24,165
Total Stockholder Equity (calculated)24,165
+/-0
Other
Capital Stock1
Cash and Short Term Investments 30,769
Common Stock Shares Outstanding 12,136
Current Deferred Revenue2,543
Liabilities and Stockholders Equity 75,268
Net Debt 1,812
Net Invested Capital 43,060
Net Working Capital 42,618
Property Plant and Equipment Gross 16,284
Short Long Term Debt Total 18,895



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-31
> Total Assets 
0
0
0
10,100
8,600
56,700
54,700
54,100
54,100
51,500
48,300
47,800
44,000
44,700
41,000
39,600
32,600
24,500
45,600
31,800
35,132
55,955
44,654
31,410
48,623
35,595
46,209
46,218
30,862
15,944
8,994
27,810
18,653
27,581
23,093
40,154
33,104
28,514
25,238
39,404
45,334
39,042
36,274
36,432
51,648
46,305
43,809
55,720
47,348
39,321
55,577
53,015
44,741
37,228
32,422
28,923
21,395
15,661
13,847
10,067
10,020
8,344
8,873
8,037
5,102
4,065
2,244
3,236
12,002
10,235
9,090
8,978
18,487
17,539
16,262
15,508
14,620
13,483
12,410
11,310
10,186
8,578
7,102
5,826
14,525
18,968
24,757
27,713
26,182
24,133
22,716
45,101
71,162
87,711
120,309
113,410
131,060
117,090
109,070
102,631
99,485
91,569
134,238
127,734
148,093
144,526
136,274
138,298
129,564
118,857
127,906
96,234
88,396
77,874
74,228
75,268
75,26874,22877,87488,39696,234127,906118,857129,564138,298136,274144,526148,093127,734134,23891,56999,485102,631109,070117,090131,060113,410120,30987,71171,16245,10122,71624,13326,18227,71324,75718,96814,5255,8267,1028,57810,18611,31012,41013,48314,62015,50816,26217,53918,4878,9789,09010,23512,0023,2362,2444,0655,1028,0378,8738,34410,02010,06713,84715,66121,39528,92332,42237,22844,74153,01555,57739,32147,34855,72043,80946,30551,64836,43236,27439,04245,33439,40425,23828,51433,10440,15423,09327,58118,65327,8108,99415,94430,86246,21846,20935,59548,62331,41044,65455,95535,13231,80045,60024,50032,60039,60041,00044,70044,00047,80048,30051,50054,10054,10054,70056,7008,60010,100000
   > Total Current Assets 
0
0
0
9,400
7,700
55,800
53,800
53,200
53,200
50,000
46,500
45,900
42,100
42,800
38,700
35,600
28,000
19,500
40,800
27,100
30,473
51,323
39,356
26,476
43,764
30,645
41,472
41,992
26,790
12,102
5,502
24,649
16,095
25,360
21,276
38,161
31,263
26,842
23,796
38,243
44,292
37,986
35,320
35,326
50,662
45,412
42,925
54,867
46,574
38,412
54,815
52,258
43,988
36,553
31,830
28,592
21,113
15,422
13,629
9,874
9,854
8,200
8,747
7,928
5,001
3,976
2,210
3,207
11,977
10,202
9,051
8,908
18,409
17,457
16,188
15,411
14,480
13,216
12,154
11,022
9,914
8,286
6,829
5,569
14,264
18,765
24,538
27,449
25,865
23,611
22,082
43,812
52,086
68,414
101,376
92,565
107,685
80,609
73,362
61,501
59,796
55,780
83,278
74,025
89,014
83,505
71,964
61,970
52,695
42,284
55,612
73,423
66,594
61,004
58,117
59,344
59,34458,11761,00466,59473,42355,61242,28452,69561,97071,96483,50589,01474,02583,27855,78059,79661,50173,36280,609107,68592,565101,37668,41452,08643,81222,08223,61125,86527,44924,53818,76514,2645,5696,8298,2869,91411,02212,15413,21614,48015,41116,18817,45718,4098,9089,05110,20211,9773,2072,2103,9765,0017,9288,7478,2009,8549,87413,62915,42221,11328,59231,83036,55343,98852,25854,81538,41246,57454,86742,92545,41250,66235,32635,32037,98644,29238,24323,79626,84231,26338,16121,27625,36016,09524,6495,50212,10226,79041,99241,47230,64543,76426,47639,35651,32330,47327,10040,80019,50028,00035,60038,70042,80042,10045,90046,50050,00053,20053,20053,80055,8007,7009,400000
       Cash And Cash Equivalents 
0
0
0
6,900
7,600
55,500
53,400
33,100
33,100
29,400
25,900
18,200
26,500
31,300
34,400
30,800
26,100
17,500
39,900
26,000
29,329
50,050
37,988
24,504
40,842
27,320
38,090
41,386
26,303
11,373
4,793
24,067
6,553
17,876
18,686
34,812
26,299
13,565
8,304
20,425
21,069
8,415
18,371
11,408
20,804
13,485
22,242
20,896
15,436
11,275
29,170
29,676
15,893
16,423
11,104
16,743
12,303
10,582
8,974
6,312
9,648
7,993
8,388
4,886
4,801
3,801
1,986
1,081
11,346
10,059
8,812
8,049
18,271
17,223
15,872
15,132
14,199
13,080
11,817
10,670
9,459
7,954
6,424
5,131
13,945
18,534
24,137
27,093
25,529
23,361
21,640
43,490
49,888
66,216
98,867
84,205
99,734
70,252
63,241
53,621
53,885
44,888
74,592
57,064
68,117
60,357
53,126
38,704
29,259
18,862
26,742
47,112
16,593
16,915
19,976
17,083
17,08319,97616,91516,59347,11226,74218,86229,25938,70453,12660,35768,11757,06474,59244,88853,88553,62163,24170,25299,73484,20598,86766,21649,88843,49021,64023,36125,52927,09324,13718,53413,9455,1316,4247,9549,45910,67011,81713,08014,19915,13215,87217,22318,2718,0498,81210,05911,3461,0811,9863,8014,8014,8868,3887,9939,6486,3128,97410,58212,30316,74311,10416,42315,89329,67629,17011,27515,43620,89622,24213,48520,80411,40818,3718,41521,06920,4258,30413,56526,29934,81218,68617,8766,55324,0674,79311,37326,30341,38638,09027,32040,84224,50437,98850,05029,32926,00039,90017,50026,10030,80034,40031,30026,50018,20025,90029,40033,10033,10053,40055,5007,6006,900000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,413
6,829
2,026
2,130
4,400
12,852
15,098
14,114
22,521
29,246
15,047
18,675
29,321
31,606
17,187
29,674
30,797
26,787
21,474
18,072
27,750
19,774
16,768
7,548
8,524
4,573
1,054
54
44
50
45
26
28
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,322
1,221
1,165
912
958
717
557
625
610
934
1,796
9,309
10,948
12,588
9,503
9,868
8,225
5,705
6,309
4,225
27,696
21,879
15,621
13,686
13,68615,62121,87927,6964,2256,3095,7058,2259,8689,50312,58810,9489,3091,7969346106255577179589121,1651,2211,3220000000000000000000000000002826455044541,0544,5738,5247,54816,76819,77427,75018,07221,47426,78730,79729,67417,18731,60629,32118,67515,04729,24622,52114,11415,09812,8524,4002,1302,0266,8298,41300000000000000000000000000000000
       Net Receivables 
0
0
0
2,500
100
100
100
0
400
500
400
600
700
700
400
300
400
400
500
700
830
993
1,126
1,478
1,065
994
156
234
149
380
341
309
417
479
178
691
220
258
42
3,336
443
199
1,565
4,905
158
146
3,089
3,919
55
111
3,710
4,046
4
49
3,565
3,918
26
43
3,300
3,287
2
0
0
2,750
2,750
0
0
1,933
1,933
0
0
669
669
0
0
0
0
0
0
24
24
24
38
38
38
34
34
34
73
73
68
242
71
0
0
310
3,124
3,056
2,643
1,293
1,872
6,871
4,078
4,645
5,838
5,767
5,418
9,803
10,086
10,260
12,560
12,973
11,108
12,529
11,656
10,138
10,13811,65612,52911,10812,97312,56010,26010,0869,8035,4185,7675,8384,6454,0786,8711,8721,2932,6433,0563,1243100071242687373343434383838242424000000669669001,9331,933002,7502,7500023,2873,30043263,9183,5654944,0463,710111553,9193,0891461584,9051,5651994433,336422582206911784794173093413801492341569941,0651,4781,12699383070050040040030040070070060040050040001001001002,500000
       Other Current Assets 
0
0
0
0
0
200
300
20,100
20,100
20,100
20,200
27,100
14,900
10,800
3,900
4,500
1,500
1,600
400
400
314
280
242
494
1,857
2,331
3,226
371
339
349
368
272
711
175
385
528
344
166
352
367
260
125
337
338
380
175
407
378
286
238
460
464
341
308
393
384
260
224
301
221
160
157
314
266
172
175
224
194
632
143
239
189
138
234
316
280
281
137
336
328
431
309
405
438
319
230
401
356
336
251
442
322
876
978
1,344
7,448
6,993
8,968
4,356
1,420
1,420
1,407
1,794
1,651
1,117
1,318
2,190
1,688
1,404
1,666
1,728
2,975
2,632
1,914
2,034
2,560
2,5602,0341,9142,6322,9751,7281,6661,4041,6882,1901,3181,1171,6511,7941,4071,4201,4204,3568,9686,9937,4481,3449788763224422513363564012303194384053094313283361372812803162341381892391436321942241751722663141571602213012242603843933083414644602382863784071753803383371252603673521663445283851757112723683493393713,2262,3311,8574942422803144004001,6001,5004,5003,90010,80014,90027,10020,20020,10020,10020,10030020000000
   > Long-term Assets 
0
0
0
700
900
900
900
900
900
1,500
1,800
1,900
1,900
1,900
2,300
4,000
4,600
5,000
4,800
4,700
4,659
4,632
5,298
4,934
4,859
4,949
4,737
4,227
4,071
3,842
3,492
3,161
2,558
2,222
1,817
1,993
1,842
1,673
1,442
1,161
1,042
1,056
953
1,106
986
893
885
853
774
909
763
757
753
675
591
331
282
239
219
193
166
144
126
109
101
90
33
29
25
33
39
70
78
82
75
96
140
266
257
288
272
292
273
257
261
203
219
264
317
521
634
1,289
19,076
19,297
18,933
20,845
23,376
36,481
35,708
41,130
39,689
35,789
50,960
53,709
59,079
61,021
64,310
76,328
76,869
76,573
72,294
22,811
21,802
16,870
16,111
15,924
15,92416,11116,87021,80222,81172,29476,57376,86976,32864,31061,02159,07953,70950,96035,78939,68941,13035,70836,48123,37620,84518,93319,29719,0761,28963452131726421920326125727329227228825726614096758278703933252933901011091261441661932192392823315916757537577639097748538858939861,1069531,0561,0421,1611,4421,6731,8421,9931,8172,2222,5583,1613,4923,8424,0714,2274,7374,9494,8594,9345,2984,6324,6594,7004,8005,0004,6004,0002,3001,9001,9001,9001,8001,500900900900900900700000
       Property Plant Equipment 
0
0
0
800
700
800
800
800
800
1,100
1,400
1,500
1,500
1,400
1,600
3,000
3,600
4,100
4,000
4,000
4,006
4,029
4,521
4,576
4,494
4,572
4,363
4,186
4,026
3,813
3,477
3,152
2,549
2,213
1,816
1,992
1,836
1,667
1,441
1,150
1,027
1,036
950
915
976
887
879
848
769
705
647
620
634
574
508
264
228
198
188
171
152
135
120
105
97
85
29
25
20
15
21
53
61
60
57
78
114
240
231
262
246
245
235
219
223
169
184
230
245
448
566
1,047
1,201
1,617
1,594
1,751
1,902
4,052
1,374
9,693
9,081
8,773
9,999
10,758
10,199
13,145
16,277
21,819
23,389
23,315
21,533
13,229
12,409
11,490
10,616
11,633
11,63310,61611,49012,40913,22921,53323,31523,38921,81916,27713,14510,19910,7589,9998,7739,0819,6931,3744,0521,9021,7511,5941,6171,2011,0475664482452301841692232192352452462622312401147857606153211520252985971051201351521711881982282645085746346206477057698488798879769159501,0361,0271,1501,4411,6671,8361,9921,8162,2132,5493,1523,4773,8134,0264,1864,3634,5724,4944,5764,5214,0294,0064,0004,0004,1003,6003,0001,6001,4001,5001,5001,4001,100800800800800700800000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,898
14,038
14,038
14,038
13,563
27,569
29,442
34,870
34,679
34,177
40,128
40,320
41,185
39,318
7,463
7,435
3,636
3,607
1,681
1,6813,6073,6367,4357,46339,31841,18540,32040,12834,17734,67934,87029,44227,56913,56314,03814,03814,03813,8980000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,805
17,458
17,110
18,785
18,350
18,192
17,268
16,895
16,289
13,143
13,015
13,210
12,834
12,691
12,358
12,203
11,900
10,952
10,049
1,063
812
537
273
1,839
1,8392735378121,06310,04910,95211,90012,20312,35812,69112,83413,21013,01513,14316,28916,89517,26818,19218,35018,78517,11017,45817,80500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
653
602
777
358
366
377
373
41
45
29
16
9
9
9
1
1
5
6
1
11
15
20
4
191
10
6
5
5
5
204
116
136
119
101
84
67
53
41
30
21
14
9
6
5
5
4
5
4
4
18
18
17
17
21
18
18
26
26
26
26
26
47
38
38
38
34
34
34
73
73
68
242
71
222
228
310
290
340
667
504
281
310
36,961
38,437
1,176
506
1,498
2,178
1,260
635
932
0
0
1,207
0
0
001,207009326351,2602,1781,4985061,17638,43736,961310281504667340290310228222712426873733434343838384726262626261818211717181844545569142130415367841011191361162045556101914201511165119991629454137337736635877760265300000000000000000000
> Total Liabilities 
0
0
0
6,500
6,500
6,500
5,900
6,400
6,400
5,700
4,200
5,700
4,700
5,100
4,500
6,400
6,400
6,100
5,300
9,800
7,276
8,852
8,547
12,353
13,944
15,760
20,263
23,006
16,868
13,244
18,045
17,299
6,098
3,054
3,133
5,278
3,196
2,678
2,549
3,682
5,091
3,172
4,609
7,046
6,712
6,950
7,641
8,739
7,722
7,060
25,993
26,118
25,990
25,822
24,305
23,001
18,857
16,077
14,151
11,993
9,203
6,727
4,612
2,704
1,712
1,281
760
704
9,582
945
726
743
795
750
501
565
756
743
11,573
11,732
12,012
12,027
11,834
11,914
9,888
8,944
8,734
6,929
6,942
7,107
7,138
6,561
3,543
4,189
6,987
3,948
6,847
7,816
8,240
8,966
8,245
7,156
21,440
24,161
25,897
27,029
26,760
30,339
30,849
29,253
44,692
29,302
26,172
24,031
23,794
51,103
51,10323,79424,03126,17229,30244,69229,25330,84930,33926,76027,02925,89724,16121,4407,1568,2458,9668,2407,8166,8473,9486,9874,1893,5436,5617,1387,1076,9426,9298,7348,9449,88811,91411,83412,02712,01211,73211,5737437565655017507957437269459,5827047601,2811,7122,7044,6126,7279,20311,99314,15116,07718,85723,00124,30525,82225,99026,11825,9937,0607,7228,7397,6416,9506,7127,0464,6093,1725,0913,6822,5492,6783,1965,2783,1333,0546,09817,29918,04513,24416,86823,00620,26315,76013,94412,3538,5478,8527,2769,8005,3006,1006,4006,4004,5005,1004,7005,7004,2005,7006,4006,4005,9006,5006,5006,500000
   > Total Current Liabilities 
0
0
0
3,700
4,000
4,200
3,600
4,200
4,200
3,800
2,500
4,500
3,600
4,100
3,800
6,400
6,300
6,000
5,300
7,800
5,521
7,344
7,291
11,347
11,125
13,204
17,975
20,734
13,544
8,679
14,581
16,933
5,836
2,815
2,824
4,755
2,697
2,158
2,032
3,263
4,771
2,862
4,362
6,815
5,958
6,436
7,372
8,598
7,608
6,977
7,409
9,328
11,040
12,739
13,141
13,810
11,696
11,002
11,221
11,269
9,203
6,727
4,612
2,704
1,712
1,281
760
704
9,582
945
726
743
795
750
501
565
756
743
764
919
2,583
2,586
971
1,054
2,413
2,586
2,567
1,316
2,813
2,988
3,003
5,062
2,044
2,634
6,921
3,874
5,004
6,183
6,948
7,947
7,541
4,179
5,555
7,976
9,970
10,021
9,958
13,186
13,872
13,175
29,749
17,005
14,037
11,907
11,827
16,726
16,72611,82711,90714,03717,00529,74913,17513,87213,1869,95810,0219,9707,9765,5554,1797,5417,9476,9486,1835,0043,8746,9212,6342,0445,0623,0032,9882,8131,3162,5672,5862,4131,0549712,5862,5839197647437565655017507957437269459,5827047601,2811,7122,7044,6126,7279,20311,26911,22111,00211,69613,81013,14112,73911,0409,3287,4096,9777,6088,5987,3726,4365,9586,8154,3622,8624,7713,2632,0322,1582,6974,7552,8242,8155,83616,93314,5818,67913,54420,73417,97513,20411,12511,3477,2917,3445,5217,8005,3006,0006,3006,4003,8004,1003,6004,5002,5003,8004,2004,2003,6004,2004,0003,700000
       Short-term Debt 
0
0
0
0
400
300
200
0
0
0
0
0
0
0
0
0
0
0
0
1,100
931
953
975
997
1,022
1,048
1,075
1,006
741
469
1,302
4,865
73
54
26
0
0
0
0
1,416
532
0
0
61
793
820
848
751
543
327
1,177
2,982
4,835
6,736
7,510
21
7,912
0
0
8,555
7,237
5,137
2,978
757
757
0
0
0
8,437
0
0
0
0
0
0
0
0
0
0
1,390
1,413
1,435
10,863
10,860
1,472
1,479
1,486
5,614
1,493
1,495
1,497
1,499
1,499
1,499
1,499
1,499
1,500
2,647
0
1,182
0
-2,196
0
1,292
1,991
2,014
1,084
1,061
989
2,039
3,922
868
868
0
0
728
728008688683,9222,0399891,0611,0842,0141,9911,2920-2,19601,18202,6471,5001,4991,4991,4991,4991,4991,4971,4951,4935,6141,4861,4791,47210,86010,8631,4351,4131,39000000000008,4370007577572,9785,1377,2378,555007,912217,5106,7364,8352,9821,17732754375184882079361005321,41600002654734,8651,3024697411,0061,0751,0481,0229979759539311,1000000000000002003004000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,390
0
0
0
1,465
0
0
0
1,491
1,493
1,495
1,497
1,499
1,499
1,499
1,499
1,499
1,500
1,500
0
0
0
0
0
1,292
1,991
2,014
1,084
0
0
1,001
3,000
0
0
0
0
0
000003,0001,001001,0842,0141,9911,292000001,5001,5001,4991,4991,4991,4991,4991,4971,4951,4931,4910001,4650001,3900000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
400
1,400
800
1,400
600
600
800
500
700
1,000
700
1,100
2,100
3,300
3,500
3,800
4,900
3,505
4,545
4,613
8,563
8,458
9,988
14,222
16,309
10,174
4,864
8,790
10,065
5,053
2,202
2,145
3,953
1,725
1,184
1,086
1,550
2,295
1,910
3,302
5,487
2,987
2,744
3,732
5,909
5,521
5,312
4,739
4,551
4,972
4,564
3,991
11,205
10,108
9,871
10,565
1,969
1,629
1,290
1,351
1,351
1,398
981
492
453
744
577
485
505
649
599
352
402
592
574
600
755
995
969
801
884
783
946
919
1,065
1,120
1,183
1,204
2,088
1,582
2,090
1,741
968
1,383
2,321
4,827
5,113
5,452
1,825
2,697
3,669
5,741
5,519
6,324
4,789
7,171
4,598
3,098
3,289
2,825
2,374
2,563
4,438
4,4382,5632,3742,8253,2893,0984,5987,1714,7896,3245,5195,7413,6692,6971,8255,4525,1134,8272,3211,3839681,7412,0901,5822,0881,2041,1831,1201,0659199467838848019699957556005745924023525996495054855777444534929811,3981,3511,3511,2901,6291,96910,5659,87110,10811,2053,9914,5644,9724,5514,7395,3125,5215,9093,7322,7442,9875,4873,3021,9102,2951,5501,0861,1841,7253,9532,1452,2025,05310,0658,7904,86410,17416,30914,2229,9888,4588,5634,6134,5453,5054,9003,8003,5003,3002,1001,1007001,0007005008006006001,4008001,400400000
       Other Current Liabilities 
0
0
0
3,300
2,200
3,100
2,000
3,600
3,600
3,000
2,000
3,800
2,600
3,400
2,700
4,300
3,000
2,500
1,500
1,800
1,085
1,846
1,704
1,787
1,645
2,167
2,678
1,368
2,534
3,251
4,394
1,892
614
463
536
707
549
709
812
200
1,777
952
1,060
228
257
326
272
127
97
105
112
120
114
83
52
2,584
1,588
1,131
656
745
337
300
283
595
314
300
268
251
401
368
242
238
146
151
149
163
164
170
164
164
175
182
170
169
158
161
162
251
200
310
303
2,974
462
545
3,681
1,406
2,121
1,214
2,121
1,652
2,089
2,354
588
664
-93
134
208
4,508
2,891
6,481
5,754
12,848
11,212
9,533
9,264
9,017
9,0179,2649,53311,21212,8485,7546,4812,8914,508208134-936645882,3542,0891,6522,1211,2142,1211,4063,6815454622,9743033102002511621611581691701821751641641701641631491511462382423684012512683003145952833003377456561,1311,5882,5845283114120112105971272723262572281,0609521,7772008127095497075364636141,8924,3943,2512,5341,3682,6782,1671,6451,7871,7041,8461,0851,8001,5002,5003,0004,3002,7003,4002,6003,8002,0003,0003,6003,6002,0003,1002,2003,300000
   > Long-term Liabilities 
0
0
0
2,800
2,500
2,300
2,300
2,200
2,200
1,900
1,700
1,200
1,100
1,000
700
0
100
100
0
2,000
1,755
1,508
1,256
1,006
2,819
2,557
2,288
2,272
3,324
4,565
3,464
366
263
239
310
523
499
520
518
420
319
310
247
230
754
515
268
140
114
83
18,585
16,790
14,950
13,082
11,164
9,191
7,162
5,075
2,930
724
724
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,808
10,813
9,430
9,441
10,863
10,860
7,475
6,358
6,167
5,614
4,129
4,119
4,135
1,499
1,499
1,554
67
74
1,843
1,633
1,292
1,019
704
2,977
15,885
16,185
15,927
17,008
16,802
17,153
16,977
16,078
14,943
12,297
12,135
12,124
11,967
34,377
34,37711,96712,12412,13512,29714,94316,07816,97717,15316,80217,00815,92716,18515,8852,9777041,0191,2921,6331,84374671,5541,4991,4994,1354,1194,1295,6146,1676,3587,47510,86010,8639,4419,43010,81310,808000000000000000007247242,9305,0757,1629,19111,16413,08214,95016,79018,585831141402685157542302473103194205185204995233102392633663,4644,5653,3242,2722,2882,5572,8191,0061,2561,5081,7552,000010010007001,0001,1001,2001,7001,9002,2002,2002,3002,3002,5002,800000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,367
1,390
0
0
0
0
0
0
0
0
0
0
0
0
0
1,499
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000001,49900000000000001,3901,367000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
438
463
390
366
262
239
310
523
498
520
518
419
319
310
247
231
212
188
165
141
114
83
52
21
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,441
9,423
9,430
9,441
9,405
9,395
7,475
6,358
6,167
4,122
4,129
4,119
4,135
0
0
55
67
74
0
0
1,292
0
0
2,455
14,814
2,351
15,158
15,377
16,802
17,247
16,083
16,078
14,943
0
0
12,124
0
0
0012,1240014,94316,07816,08317,24716,80215,37715,1582,35114,8142,455001,29200746755004,1354,1194,1294,1226,1676,3587,4759,3959,4059,4419,4309,4239,441000000000000000000000000002152831141411651882122312473103194195185204985233102392623663904634380000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,441
9,423
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000009,4239,441000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
3,600
2,100
50,200
48,700
47,700
47,700
45,800
44,000
42,000
39,200
39,500
36,400
33,200
26,200
18,400
40,300
22,000
27,837
47,084
36,089
19,040
34,662
19,817
25,929
23,195
13,976
2,683
-9,068
10,494
12,538
24,510
19,942
34,859
29,892
25,819
22,672
35,705
40,227
35,853
31,648
29,369
44,918
39,337
36,151
46,963
39,608
32,243
29,566
26,897
18,751
11,406
8,117
5,922
2,537
-416
-304
-1,926
817
1,616
4,261
5,333
3,390
2,784
1,483
2,532
2,420
9,290
8,364
8,235
17,693
16,789
15,761
14,942
13,864
12,739
838
-422
-1,826
-3,449
-4,733
-6,087
4,637
10,024
16,023
20,784
19,240
17,026
15,578
38,540
67,619
83,522
113,321
109,462
104,196
89,038
80,371
72,995
70,362
63,339
91,527
81,540
100,032
94,800
86,607
84,502
74,989
66,943
61,711
44,574
39,580
32,226
28,794
24,165
24,16528,79432,22639,58044,57461,71166,94374,98984,50286,60794,800100,03281,54091,52763,33970,36272,99580,37189,038104,196109,462113,32183,52267,61938,54015,57817,02619,24020,78416,02310,0244,637-6,087-4,733-3,449-1,826-42283812,73913,86414,94215,76116,78917,6938,2358,3649,2902,4202,5321,4832,7843,3905,3334,2611,616817-1,926-304-4162,5375,9228,11711,40618,75126,89729,56632,24339,60846,96336,15139,33744,91829,36931,64835,85340,22735,70522,67225,81929,89234,85919,94224,51012,53810,494-9,0682,68313,97623,19525,92919,81734,66219,04036,08947,08427,83722,00040,30018,40026,20033,20036,40039,50039,20042,00044,00045,80047,70047,70048,70050,2002,1003,600000
   Common Stock
0
0
0
100
-3,000
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
154
171
171
172
188
189
189
218
225
225
225
241
253
325
325
378
378
379
379
436
507
507
509
511
741
741
741
848
849
850
850
857
857
884
884
885
886
887
887
887
957
96
115
115
116
116
122
122
122
226
226
226
271
271
271
271
271
271
325
325
325
325
325
325
427
476
495
603
603
603
603
699
797
866
935
954
958
958
964
979
1,010
1,010
1,240
1,240
1,399
1,399
1,399
1,399
1,374
1,373
1,373
1
1
1
1
1
111111,3731,3731,3741,3991,3991,3991,3991,2401,2401,0101,010979964958958954935866797699603603603603495476427325325325325325325271271271271271271226226226122122122116116115115969578878878878868858848848578578508508498487417417415115095075074363793793783783253252532412252252252181891891881721711711541001000000000000000-3,000100000
   Retained Earnings Total Equity00000000-605,643-599,968-590,263-583,8360-556,811-540,364-532,032-523,900-512,074-502,428-487,115-478,941-469,677-460,920-455,061-452,702-447,654-446,041-443,632-441,932-439,258-437,565-434,273-432,478-430,776-429,171-427,075-425,272-423,675-402,137-400,521-399,07000000000-379,791-378,48200000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-200
-300
-300
-400
-400
-500
-600
-700
-900
-1,100
-1,300
-1,500
-1,700
-1,900
-2,100
-2,300
-2,564
-2,819
-3,094
-3,400
-3,400
-3,400
-3,400
-73
-62
-62
-62
-62
-6,203
-6,203
-6,203
-4,325
-4,325
-4,325
-4,325
-5,711
-5,711
-5,711
-5,711
-102
-4,695
-4,695
-4,695
117
149
131
82
67
50
10
-74
-58
-82
-63
-71
-6,144
-6,144
0
0
-6,195
2
0
0
-393
-393
0
0
-284
-284
0
0
-177
-177
0
0
-225
-225
0
0
-294
-434,000
0
0
-262
-262
0
0
-372
527
-540
-1,225
-1,226
-915
-2,027
-3,863
-2,728
-3,554
-3,890
-1,507
589
485
1,159
1,169
1,954
2,129
-160
-1,951
-703
-613
-1,594
-1,619
-1,200
-1,200-1,619-1,594-613-703-1,951-1602,1291,9541,1691,159485589-1,507-3,890-3,554-2,728-3,863-2,027-915-1,226-1,225-540527-37200-262-26200-434,000-29400-225-22500-177-17700-284-28400-393-393002-6,19500-6,144-6,144-71-63-82-58-7410506782131149117-4,695-4,695-4,695-102-5,711-5,711-5,711-5,711-4,325-4,325-4,325-4,325-6,203-6,203-6,203-62-62-62-62-73-3,400-3,400-3,400-3,400-3,094-2,819-2,564-2,300-2,100-1,900-1,700-1,500-1,300-1,100-900-700-600-500-400-400-300-300-2000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
384,870
385,836
0
0
0
0
0
0
0
0
421,775
422,147
422,639
432,222
432,559
432,958
433,431
433,752
434,100
446,517
455,147
456,546
470,147
470,303
470,498
470,663
498,577
529,389
552,094
590,322
596,711
599,302
600,569
603,378
606,686
612,972
614,617
656,639
0
690,018
690,539
692,041
694,826
0
0
0
0
0
0
0
0
00000000694,826692,041690,539690,0180656,639614,617612,972606,686603,378600,569599,302596,711590,322552,094529,389498,577470,663470,498470,303470,147456,546455,147446,517434,100433,752433,431432,958432,559432,222422,639422,147421,77500000000385,836384,87000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000-8,034-8,034-8,034-8,0340-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-8,034-7,667-7,667-7,667-7,667-7,667-7,667-7,667-7,667-3,833-3,833-3,83300000000000000000000
   Other Stockholders Equity 
0
0
0
24,000
24,500
73,100
73,000
73,400
73,400
74,200
74,300
74,500
75,000
77,300
78,400
80,000
80,400
80,800
109,700
106,400
123,101
155,719
156,278
153,272
179,474
179,504
179,451
202,067
207,355
207,313
207,314
220,283
232,148
249,307
249,335
268,268
268,268
268,442
268,442
283,064
292,971
292,898
293,070
287,358
341,981
342,426
342,765
354,284
354,571
355,158
355,564
356,671
356,889
359,127
359,319
359,656
359,810
359,888
359,924
359,964
364,763
371,367
376,088
382,290
376,746
377,800
377,802
378,238
380,267
400,847
401,109
401,624
411,889
412,837
413,251
413,918
414,113
414,605
424,188
424,750
424,924
425,397
425,718
426,359
872,483
447,113
454,786
462,375
462,269
462,463
462,629
490,915
521,355
544,116
583,288
588,676
591,268
592,535
595,344
598,652
604,938
606,583
648,605
650,212
681,984
682,505
684,007
686,792
685,112
686,301
687,145
682,436
682,516
685,620
686,079
686,181
686,181686,079685,620682,516682,436687,145686,301685,112686,792684,007682,505681,984650,212648,605606,583604,938598,652595,344592,535591,268588,676583,288544,116521,355490,915462,629462,463462,269462,375454,786447,113872,483426,359425,718425,397424,924424,750424,188414,605414,113413,918413,251412,837411,889401,624401,109400,847380,267378,238377,802377,800376,746382,290376,088371,367364,763359,964359,924359,888359,810359,656359,319359,127356,889356,671355,564355,158354,571354,284342,765342,426341,981287,358293,070292,898292,971283,064268,442268,442268,268268,268249,335249,307232,148220,283207,314207,313207,355202,067179,451179,504179,474153,272156,278155,719123,101106,400109,70080,80080,40080,00078,40077,30075,00074,50074,30074,20073,40073,40073,00073,10024,50024,000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue33,879
Cost of Revenue-14,895
Gross Profit18,98418,984
 
Operating Income (+$)
Gross Profit18,984
Operating Expense-50,630
Operating Income-31,646-31,646
 
Operating Expense (+$)
Research Development8,793
Selling General Administrative25,387
Selling And Marketing Expenses16,450
Operating Expense50,63050,630
 
Net Interest Income (+$)
Interest Income614
Interest Expense-0
Other Finance Cost-0
Net Interest Income614
 
Pretax Income (+$)
Operating Income-31,646
Net Interest Income614
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-26,292-37,000
EBIT - interestExpense = -31,646
-27,019
-26,938
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-31,646-26,292
Earnings Before Interest and Taxes (EBITDA)-27,905
 
After tax Income (+$)
Income Before Tax-26,292
Tax Provision--81
Net Income From Continuing Ops-26,259-26,211
Net Income-26,938
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses65,525
Total Other Income/Expenses Net5,354-614
 

Technical Analysis of CASI Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of CASI Pharmaceuticals Inc. The general trend of CASI Pharmaceuticals Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine CASI Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of CASI Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.45 < 2.9201 < 2.93.

The bearish price targets are: 2 > 1.9899 > 1.9.

Tweet this
CASI Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of CASI Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

CASI Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of CASI Pharmaceuticals Inc. The current macd is -0.50103524.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the CASI Pharmaceuticals Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for CASI Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the CASI Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
CASI Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartCASI Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of CASI Pharmaceuticals Inc. The current adx is 27.21.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell CASI Pharmaceuticals Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
CASI Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of CASI Pharmaceuticals Inc. The current sar is 3.50147368.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
CASI Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of CASI Pharmaceuticals Inc. The current rsi is 23.92. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
CASI Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartCASI Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of CASI Pharmaceuticals Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the CASI Pharmaceuticals Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
CASI Pharmaceuticals Inc Daily Stochastic Oscillator ChartCASI Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of CASI Pharmaceuticals Inc. The current cci is -227.93843796.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
CASI Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartCASI Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of CASI Pharmaceuticals Inc. The current cmo is -62.99407301.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
CASI Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartCASI Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of CASI Pharmaceuticals Inc. The current willr is -84.66777103.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
CASI Pharmaceuticals Inc Daily Williams %R ChartCASI Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of CASI Pharmaceuticals Inc. The current atr is 0.32281065.

CASI Pharmaceuticals Inc Daily Average True Range (ATR) ChartCASI Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of CASI Pharmaceuticals Inc. The current obv is 15,646,266.

CASI Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartCASI Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of CASI Pharmaceuticals Inc. The current mfi is 49.86.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
CASI Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartCASI Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for CASI Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

CASI Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of CASI Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.915
Ma 20Greater thanMa 503.057
Ma 50Greater thanMa 1004.439
Ma 100Greater thanMa 2005.372
OpenGreater thanClose2.300
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of CASI Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on CASI Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about CASI Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about CASI Pharmaceuticals Inc

I send you an email if I find something interesting about CASI Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about CASI Pharmaceuticals Inc.

Receive notifications about CASI Pharmaceuticals Inc in your mailbox!